Skip to content
Disclosery

Ikarian Capital, LLC

Follow

13F filer, CIK 1778253, DALLAS, TX

Ikarian Capital, LLC reported $520,629,177 across 133 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 44.95% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-25-002181

Period
2025-06-30
Reported value
$521M
Holdings
133
Top 10 weight
44.95%
New
41
Sold out
68

Part of the filer group Ikarian Capital, LLC

  • Neil Shahrestani
How groups are built

Stakes and trades reported after 2025-06-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • QNRX QUOIN PHARMACEUTICALS LTD: 13G/A 211,538 shares, 4.4% of the class, 13G/A filed 2026-10-07, 0001778253-26-000004Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CDTXadded+215,548$10.5M
APGEnew+232,047$10.1M
ALNYadded+25,000$8.15M
INSMadded+78,951$7.95M
COGTnew+1,035,528$7.44M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SPYexited-25,000-$14M
TARSreduced-288,485-$11.7M
BLUEPRINT MEDICINES CORPexited-113,904-$10.1M
RAREexited-216,989-$7.86M
SRRKreduced-195,000-$6.91M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001420506-25-002181, largest first. % of portfolio is the value over $302,227,365, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CDTXCIDARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 53,940 shares; 2025Q1: 248,940 shares; 2025Q2: 464,488 shares 464,488$22.6M7.49%+215,548Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,741 shares; 2024Q4: not reported; 2025Q1: 31,594 shares; 2025Q2: 56,594 shares 56,594$18.5M6.11%+25,000Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 154,835 shares; 2024Q4: 119,800 shares; 2025Q1: 84,800 shares; 2025Q2: 163,751 shares 163,751$16.5M5.45%+78,951Timeline
VERONA PHARMA PLCVERONA PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 80,000 shares; 2025Q1: 130,000 shares; 2025Q2: 146,831 shares 146,831$13.9M4.59%+16,831
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 426,913 shares; 2024Q4: 516,431 shares; 2025Q1: 523,431 shares; 2025Q2: 433,431 shares 433,431$12.5M4.12%-90,000Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 245,000 shares; 2025Q2: 220,000 shares 220,000$11.7M3.88%-25,000Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 145,502 shares; 2025Q2: 276,950 shares 276,950$11.6M3.85%+131,448Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 232,047 shares 232,047$10.1M3.33%newTimeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 200,000 shares; 2025Q2: 305,000 shares 305,000$9.92M3.28%+105,000Timeline
ACOGALPHA COGNITION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 755,867 shares; 2025Q1: 967,867 shares; 2025Q2: 917,867 shares 917,867$8.56M2.83%-50,000Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,030,277 shares; 2024Q4: 607,689 shares; 2025Q1: 485,021 shares; 2025Q2: 196,536 shares 196,536$7.96M2.63%-288,485Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 170,147 shares; 2024Q4: 149,982 shares; 2025Q1: 149,982 shares; 2025Q2: 233,464 shares 233,464$7.71M2.55%+83,482Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 54,176 shares; 2024Q4: 34,087 shares; 2025Q1: 169,087 shares; 2025Q2: 449,087 shares 449,087$7.68M2.54%+280,000Timeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 291,240 shares; 2025Q1: 210,065 shares; 2025Q2: 209,938 shares 209,938$7.56M2.5%-127Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,035,528 shares 1,035,528$7.44M2.46%newTimeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 499,977 shares; 2024Q4: 469,949 shares; 2025Q1: 494,949 shares; 2025Q2: 469,949 shares 469,949$6.57M2.17%-25,000Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 229,900 shares; 2025Q2: 850,000 shares 850,000$6.26M2.07%+620,100Timeline
FBRXFORTE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 609,225 shares; 2025Q1: 609,225 shares; 2025Q2: 476,443 shares 476,443$6.16M2.04%-132,782Timeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 897,862 shares; 2025Q1: 1,068,062 shares; 2025Q2: 1,068,062 shares 1,068,062$5.38M1.78%0Timeline
CPRXCATALYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 417,850 shares; 2024Q4: 349,649 shares; 2025Q1: 249,649 shares; 2025Q2: 209,649 shares 209,649$4.55M1.51%-40,000Timeline
DCTHDELCATH SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 100,370 shares; 2024Q4: 100,365 shares; 2025Q1: 100,365 shares; 2025Q2: 322,390 shares 322,390$4.38M1.45%+222,025Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 40,000 shares 40,000$4.24M1.4%newTimeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 155,000 shares 155,000$4.03M1.33%newTimeline
STIMNEURONETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,100,000 shares; 2025Q2: 1,099,700 shares 1,099,700$3.84M1.27%-300Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 115,200 shares; 2024Q4: 284,085 shares; 2025Q1: 264,085 shares; 2025Q2: 183,085 shares 183,085$3.8M1.26%-81,000Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 206,800 shares 206,800$3.75M1.24%newTimeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 358,837 shares; 2025Q2: 363,837 shares 363,837$3.46M1.15%+5,000Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 267,145 shares; 2024Q4: 142,328 shares; 2025Q1: 269,090 shares; 2025Q2: 163,696 shares 163,696$3.25M1.08%-105,394Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 322,740 shares; 2025Q2: 262,740 shares 262,740$3.22M1.07%-60,000Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 74,691 shares; 2025Q1: 129,691 shares; 2025Q2: 129,691 shares 129,691$3M0.99%0Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 75,000 shares; 2024Q4: 200,096 shares; 2025Q1: 200,096 shares; 2025Q2: 428,521 shares 428,521$2.95M0.98%+228,425Timeline
ELDNELEDON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,126,637 shares; 2025Q1: 1,025,221 shares; 2025Q2: 1,000,221 shares 1,000,221$2.71M0.9%-25,000Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 21,516 shares 21,516$2.7M0.89%newTimeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 50,000 shares; 2025Q2: 100,000 shares 100,000$2.65M0.88%+50,000Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 693,350 shares; 2024Q4: 693,308 shares; 2025Q1: 743,308 shares; 2025Q2: 743,308 shares 743,308$2.57M0.85%0Timeline
ARCTARCTURUS THERAPEUTICS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 200,000 shares; 2025Q1: 175,000 shares; 2025Q2: 175,000 shares 175,000$2.28M0.75%0Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 150,000 shares; 2025Q2: 1,600,000 shares 1,600,000$2.26M0.75%+1,450,000Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 198,528 shares 198,528$2.24M0.74%newTimeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 476,586 shares; 2024Q4: 576,166 shares; 2025Q1: 649,534 shares; 2025Q2: 599,534 shares 599,534$2.24M0.74%-50,000Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 257,216 shares; 2024Q4: 499,301 shares; 2025Q1: 550,029 shares; 2025Q2: 550,029 shares 550,029$2.21M0.73%0Timeline
MTSRMETSERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 150,000 shares; 2025Q2: 77,316 shares 77,316$2.2M0.73%-72,684Timeline
VTYXVENTYX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 192,647 shares; 2024Q4: 1,092,590 shares; 2025Q1: 1,217,590 shares; 2025Q2: 967,590 shares 967,590$2.07M0.69%-250,000Timeline
CPIXCUMBERLAND PHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 740,000 shares; 2025Q2: 595,932 shares 595,932$2M0.66%-144,068Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 483,583 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 868,069 shares 868,069$1.77M0.59%newTimeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 357,185 shares; 2025Q1: 244,179 shares; 2025Q2: 49,179 shares 49,179$1.74M0.58%-195,000Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 152,211 shares; 2025Q1: 65,431 shares; 2025Q2: 65,431 shares 65,431$1.71M0.57%0Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 119,986 shares 119,986$1.67M0.55%newTimeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 587,343 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 873,568 shares 873,568$1.4M0.46%newTimeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 744,000 shares; 2024Q4: 378,363 shares; 2025Q1: 163,363 shares; 2025Q2: 163,363 shares 163,363$1.33M0.44%0Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 3,594 shares; 2025Q1: 75,000 shares; 2025Q2: 75,000 shares 75,000$1.3M0.43%0Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 950,000 shares; 2025Q1: 950,000 shares; 2025Q2: 900,000 shares 900,000$1.26M0.42%-50,000Timeline
NUVBNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 83,282 shares; 2024Q4: 83,407 shares; 2025Q1: 619,258 shares; 2025Q2: 619,258 shares 619,258$1.21M0.4%0Timeline
VTGNVISTAGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 77,616 shares; 2025Q1: 601,703 shares; 2025Q2: 601,703 shares 601,703$1.2M0.4%0Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 367,195 shares; 2024Q4: 397,175 shares; 2025Q1: 397,175 shares; 2025Q2: 140,475 shares 140,475$1.18M0.39%-256,700Timeline
Tourmaline Bio IncTourmaline Bio IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 108,483 shares; 2024Q4: 67,927 shares; 2025Q1: 67,927 shares; 2025Q2: 67,927 shares 67,927$1.09M0.36%0
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 544,265 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 161,137 shares 161,137$1.05M0.35%newTimeline
Veru IncVeru IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 946,382 shares; 2024Q4: 945,239 shares; 2025Q1: 1,425,239 shares; 2025Q2: 1,425,239 shares 1,425,239$829K0.27%0
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 175,000 shares; 2025Q2: 68,574 shares 68,574$769K0.25%-106,426Timeline
IBBISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,755 shares 5,755$728K0.24%newTimeline
SGMOQSANGAMO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,860,179 shares; 2025Q1: 1,860,179 shares; 2025Q2: 1,260,179 shares 1,260,179$682K0.23%-600,000Timeline
IMUXIMMUNIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 493,496 shares; 2024Q4: 1,614,170 shares; 2025Q1: 914,170 shares; 2025Q2: 914,170 shares 914,170$638K0.21%0Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 42,123 shares; 2024Q4: 42,122 shares; 2025Q1: 42,122 shares; 2025Q2: 42,122 shares 42,122$601K0.2%0Timeline
IFRXINFLARX NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 704,987 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 705,010 shares 705,010$557K0.18%newTimeline
KZRKEZAR LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 106,901 shares; 2025Q1: 106,901 shares; 2025Q2: 106,901 shares 106,901$490K0.16%0Timeline
VYNEVYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 290,000 shares 290,000$479K0.16%newTimeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 600,000 shares; 2024Q4: 599,913 shares; 2025Q1: 599,913 shares; 2025Q2: 599,913 shares 599,913$458K0.15%0Timeline
MIND MEDICINE MINDMED INCMIND MEDICINE MINDMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 62,481 shares; 2024Q4: 62,691 shares; 2025Q1: 62,691 shares; 2025Q2: 62,691 shares 62,691$407K0.13%0
BIOMX INCBIOMX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 893,000 shares; 2024Q4: 892,976 shares; 2025Q1: 892,976 shares; 2025Q2: 892,976 shares 892,976$402K0.13%0
LYELLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 43,799 shares 43,799$387K0.13%newTimeline
NYXHNYXOAH S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,699 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,627 shares 50,627$379K0.13%newTimeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 15,662 shares 15,662$348K0.12%newTimeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 14,096 shares 14,096$332K0.11%newTimeline
ZYMEZYMEWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 25,000 shares 25,000$314K0.1%newTimeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 266,435 shares; 2024Q4: 265,769 shares; 2025Q1: 265,769 shares; 2025Q2: 265,769 shares 265,769$308K0.1%0Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 49,415 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 49,396 shares 49,396$266K0.09%newTimeline
VIGIL NEUROSCIENCE INCVIGIL NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 500,000 shares; 2025Q1: 250,000 shares; 2025Q2: 31,360 shares 31,360$249K0.08%-218,640
CHEMOMAB THERAPEUTICS LTDCHEMOMAB THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 213,392 shares; 2024Q4: 213,052 shares; 2025Q1: 213,052 shares; 2025Q2: 213,052 shares 213,052$247K0.08%0
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 350,000 shares; 2025Q1: 175,000 shares; 2025Q2: 110,000 shares 110,000$242K0.08%-65,000Timeline
RNACCARTESIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 52,193 shares; 2024Q4: 52,166 shares; 2025Q1: 22,166 shares; 2025Q2: 22,166 shares 22,166$230K0.08%0Timeline
ANEBANEBULO PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 157,862 shares; 2024Q4: 157,720 shares; 2025Q1: 157,720 shares; 2025Q2: 157,720 shares 157,720$227K0.08%0Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 308,497 shares; 2024Q4: 308,491 shares; 2025Q1: 308,491 shares; 2025Q2: 58,491 shares 58,491$218K0.07%-250,000Timeline
EVAXEVAXION ASQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 80,000 shares; 2025Q2: 80,000 shares 80,000$196K0.06%0Timeline
FTHFAETH THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,497 shares 22,497$193K0.06%newTimeline
LYRALYRA THERAPEUTICS INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 21,161 shares 21,161$190K0.06%newTimeline
AETHLON MED INCAETHLON MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 153,659 shares 153,659$184K0.06%new
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 970,359 shares; 2024Q4: 970,259 shares; 2025Q1: 200,000 shares; 2025Q2: 35,300 shares 35,300$176K0.06%-164,700Timeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 55,857 shares; 2024Q4: 55,766 shares; 2025Q1: 55,766 shares; 2025Q2: 55,766 shares 55,766$173K0.06%0Timeline
LXRXLEXICON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,550,000 shares; 2025Q1: 1,417,952 shares; 2025Q2: 176,479 shares 176,479$167K0.06%-1,241,473Timeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 150,000 shares; 2025Q2: 150,000 shares 150,000$166K0.06%0Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 55,175 shares; 2024Q4: 55,107 shares; 2025Q1: 25,107 shares; 2025Q2: 25,107 shares 25,107$139K0.05%0Timeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 27,257 shares; 2025Q2: 27,257 shares 27,257$117K0.04%0Timeline
MGNXMACROGENICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 80,079 shares; 2024Q4: 80,071 shares; 2025Q1: 80,071 shares; 2025Q2: 80,071 shares 80,071$96.9K0.03%0Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 387,565 shares; 2024Q4: 11,984 shares; 2025Q1: 11,984 shares; 2025Q2: 11,984 shares 11,984$91.3K0.03%0Timeline
AIRSAIRSCULPT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 17,951 shares 17,951$86.7K0.03%newTimeline
SPRUCE BIOSCIENCES INCSPRUCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,000,000 shares; 2025Q1: 1,000,000 shares; 2025Q2: 1,000,000 shares 1,000,000$72.5K0.02%0
TKNOALPHA TEKNOVA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 14,008 shares; 2025Q2: 14,008 shares 14,008$68.8K0.02%0Timeline
HOOKHOOKIPA PHARMA INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 53,076 shares; 2024Q4: 52,996 shares; 2025Q1: 52,996 shares; 2025Q2: 52,996 shares 52,996$66.5K0.02%0Timeline
TOVXTHERIVA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 120,031 shares; 2025Q2: 120,031 shares 120,031$52.1K0.02%0Timeline
TRAWTRAWS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 98,493 shares; 2025Q1: 28,493 shares; 2025Q2: 28,493 shares 28,493$42.2K0.01%0Timeline
AMIXAUTONOMIX MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 20,000 shares; 2025Q1: 20,000 shares; 2025Q2: 20,000 shares 20,000$31.4K0.01%0Timeline
SYBXSYNLOGIC INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 20,448 shares; 2024Q4: 20,422 shares; 2025Q1: 20,422 shares; 2025Q2: 20,422 shares 20,422$25.9K0.01%0Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,369 shares; 2024Q4: 40,270 shares; 2025Q1: 40,270 shares; 2025Q2: 40,270 shares 40,270$24.2K0.01%0Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 15,457 shares; 2025Q2: 12,498 shares 12,498$9.16K<0.01%-2,959Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
CDTXCIDARA THERAPEUTICS INC COM NEWput501,600$24.4Mnew
RAREULTRAGENYX PHARMACEUTICAL IN COMcall563,100$20.5M+450,000
SLNOSOLENO THERAPEUTICS INC COMput200,000$16.8M+100,000
SLNOSOLENO THERAPEUTICS INC COMcall200,000$16.8M-43,000
CDTXCIDARA THERAPEUTICS INC COM NEWcall321,000$15.6Mnew
CAPRCAPRICOR THERAPEUTICS INC COMMON STOCKput1,360,200$13.5Mnew
UNIQURE NVUNIQURE NV CALLcall800,000$11.2Mnew
RAREULTRAGENYX PHARMACEUTICAL IN COMput300,000$10.9M+200,000
PRAXPRAXIS PRECISION MEDICINES I COM NEWcall242,400$10.2Mnew
VKTXVIKING THERAPEUTICS INC COMcall350,000$9.28M+200,000
MLTXMOONLAKE IMMUNOTHERAPEUTICS Stockput194,500$9.18M+100,000
CAPRCAPRICOR THERAPEUTICS INC COMMON STOCKcall700,000$6.95M+300,000
SRPTSAREPTA THERAPEUTICS INC COMcall332,100$5.68Mnew
CYTKCYTOKINETICS INC COM NEWcall150,000$4.96Mnew
KALVKALVISTA PHARMACEUTICALS INC COMcall400,000$4.52Mnew
MLTXMOONLAKE IMMUNOTHERAPEUTICS Stockcall94,500$4.46M0
BIOHAVEN LTDBIOHAVEN LTD COMcall300,000$4.23Mnew
FULCFULCRUM THERAPEUTICS INC COMMON STOCKcall534,000$3.67Mnew
VERAVERA THERAPEUTICS INC COMMON STOCKcall153,200$3.61Mnew
SRRKSCHOLAR ROCK HLDG CORP COMcall100,000$3.54M0
APGEAPOGEE THERAPEUTICS INC Stockput79,100$3.44M+8,400
TEVATEVA PHARMACEUTICAL INDS LTD ADRcall200,000$3.35M0
ALTALTIMMUNE INC COM NEWcall827,500$3.2Mnew
CNTACENTESSA PHARMACEUTICALS PLC SPONSORED ADScall200,000$2.63Mnew
AKROAKERO THERAPEUTICS INC COMcall44,400$2.37Mnew
COGTCOGENT BIOSCIENCES INC COMcall262,600$1.89Mnew
PRTAPROTHENA CORP PLC Stockcall100,000$607K0
KYMRKYMERA THERAPEUTICS INC COMput10,000$436K-166,800
APGEAPOGEE THERAPEUTICS INC Stockcall8,400$365Knew
PCVXVAXCYTE INC Stockcall6,900$224Knew

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SPYSTATE STR SPDR S&P 500 ETF T320,000$179Mput
LLYELI LILLY & CO150,000$124Mput
CORTCORCEPT THERAPEUTICS INC287,900$32.9Mput
BBIOBRIDGEBIO PHARMA INC655,400$22.7Mcall
SPYSTATE STR SPDR S&P 500 ETF T25,000$14Mshares
CORTCORCEPT THERAPEUTICS INC100,000$11.4Mcall
BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORP113,904$10.1Mshares
RNAMAVIDITY BIOSCIENCES INC300,000$8.86Mput
BHVNBIOHAVEN LTD348,200$8.37Mcall
RAREULTRAGENYX PHARMACEUTICAL IN216,989$7.86Mshares
TRUPTRUPANION INC200,000$7.45Mcall
ACLXARCELLX INC111,600$7.32Mput
IMVTIMMUNOVANT INC400,000$6.84Mput
EWTXEDGEWISE THERAPEUTICS INC280,000$6.16Mshares
ELVNENLIVEN THERAPEUTICS INC289,538$5.7Mshares
PTGXPROTAGONIST THERAPEUTICS INC100,000$4.84Mput
PTGXPROTAGONIST THERAPEUTICS INC100,000$4.84Mcall
INCYINCYTE CORP60,400$3.66Mcall
TRVITREVI THERAPEUTICS INC575,000$3.62Mshares
QUREUNIQURE NV300,000$3.18Mcall
BBIOBRIDGEBIO PHARMA INC90,837$3.14Mshares
KROSKEROS THERAPEUTICS INC274,009$2.79Mshares
KYMRKYMERA THERAPEUTICS INC100,000$2.74Mcall
ABEOABEONA THERAPEUTICS INC533,581$2.54Mshares
EOLSEVOLUS INC193,265$2.32Mshares
DYNDYNE THERAPEUTICS INC187,000$1.96Mcall
VERVE THERAPEUTICS INCVERVE THERAPEUTICS INC358,393$1.64Mshares
ARCTARCTURUS THERAPEUTICS HLDGS150,000$1.59Mcall
HROWHARROW INC58,300$1.55Mcall
TRUPTRUPANION INC40,000$1.49Mput
RCKTROCKET PHARMACEUTICALS INC221,911$1.48Mshares
CMPXCOMPASS THERAPEUTICS INC662,200$1.26Mput
CMPXCOMPASS THERAPEUTICS INC662,200$1.26Mcall
ALTALTIMMUNE INC240,000$1.2Mput
TDOCTELADOC HEALTH INC150,000$1.19Mshares
OKURONKURE THERAPEUTICS INC253,754$1.09Mshares
CRVSCORVUS PHARMACEUTICALS INC338,100$1.08Mcall
NEKTAR THERAPEUTICSNEKTAR THERAPEUTICS1,579,528$1.07Mshares
SLDBSOLID BIOSCIENCES INC230,000$851Kshares
89BIO INC89BIO INC100,000$727Kshares
OLMAOLEMA PHARMACEUTICALS INC191,994$722Kshares
IMUXIMMUNIC INC635,800$693Kcall
GLUEMONTE ROSA THERAPEUTICS INC136,575$634Kshares
CHANNEL THERAPEUTICS CORPORACHANNEL THERAPEUTICS CORPORA440,849$626Kshares
PYXSPYXIS ONCOLOGY INC613,253$601Kshares
IRONDISC MEDICINE INC11,900$591Kcall
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC12,519$552Kshares
MLYSMINERALYS THERAPEUTICS INC34,300$545Kcall
LYELL IMMUNOPHARMA INCLYELL IMMUNOPHARMA INC876,037$471Kshares
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INC78,585$469Kshares
Aethlon Medical Inc OLDAethlon Medical Inc OLD1,229,285$440Kshares
CELCCELCUITY INC39,900$403Kput
THRDTHIRD HARMONIC BIO INC100,000$347Kshares
DNAGINKGO BIOWORKS HOLDINGS INC58,300$332Kshares
TYRATYRA BIOSCIENCES INC35,000$326Kshares
CLDXCELLDEX THERAPEUTICS INC NEW17,800$323Kput
CLDXCELLDEX THERAPEUTICS INC NEW17,800$323Kcall
ALLAKOS INCALLAKOS INC1,171,950$267Kshares
ACRSACLARIS THERAPEUTICS INC150,900$231Kshares
MNPRMONOPAR THERAPEUTICS INC5,908$215Kshares
CLYMCLIMB BIO INC175,088$214Kshares
ELEVATION ONCOLOGY INC COMELEVATION ONCOLOGY INC COM690,050$179Kshares
SENSEI BIOTHERAPEUTICS INCSENSEI BIOTHERAPEUTICS INC449,963$177Kshares
CRVSCORVUS PHARMACEUTICALS INC50,000$159Kput
CELCCELCUITY INC14,900$151Kcall
RZLTREZOLUTE INC50,058$145Kshares
LYRA THERAPEUTICS INCLYRA THERAPEUTICS INC1,058,148$134Kshares
LRMRLARIMAR THERAPEUTICS INC58,526$126Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-25-002181 base2025-08-14acceptance time not in the bulk data set